SML3420

KY-226

≥97% (HPLC)

• Sinónimos: 4-((Biphenyl-4-ylmethylthio)methyl)-N-(hexylsulfonyl)benzamide, 4-(Biphenyl-4-ylmethylsulfanylmethyl)-N-(hexane-1-sulfonyl)benzoylamide, 4-[[([1,1′-Biphenyl]-4-ylmethyl)thio]methyl]-N-(hexylsulfonyl)benzamide
• Fórmula empírica (notación de Hill): C₂₇H₃₁NO₃S₂
• Número de CAS: 1621673-53-7
• Peso molecular: 481.67
• MDL number: MFCD32263946
• UNSPSC Code: 12352200
• NACRES: NA.77

Propiedades

• Quality Level: 100
• assay: ≥97% (HPLC)
• form: powder
• color: white to beige
• solubility: DMSO: 2 mg/mL, clear
• storage temp.: 2-8°C
• SMILES string: O=C(NS(=O)(CCCCCC)=O)C1=CC=C(CSCC2=CC=C(C3=CC=CC=C3)C=C2)C=C1

Descripción

Biochem/physiol Actions

KY-226 is an orally bioavailable, potent and selective allosteric inhibitor of protein tyrosine phosphatase 1B (PTP1B) that does not function as a PPARg agonist. KY-226 exhibits anti-diabetic, anti-obesity effects by enhancement of insulin and leptin signaling in mice. It appears that KY-226 exerts neuroprotective effects through restoration of phosphorylation of Akt and FoxO1. Thus, it protects BBB integrity by restoration of tight junction (TJ) proteins in mice.

Información de seguridad

• Storage Class: 11 - Combustible Solids
• wgk_germany: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable